Trademark: 79354242
Status Date
Tuesday, March 12, 2024
Filing Date
Tuesday, September 20, 2022
Published for Opposition
Tuesday, March 12, 2024
5 Chemical preparations for pharmaceutical purposes, namely, for curing illness or lessening the symptoms of illness; chemical preparations for medical purposes, namely, for curing illness or lessening the symptoms of illness; diagnostic agents for pharmaceutical use; diagnostic preparations for medical purposes; diagnostic and tumor suppressing agents for nuclear medicine; radioactive substances for medical purposes
35 Retail and wholesale store services featuring pharmaceutical and medical products, chemicals and chemical agents and radionuclides
1 Chemicals for use in nuclear medicine, not for medical purposes or veterinary purposes; chemical preparations for use in the manufacture of pharmaceuticals; diagnostic preparations for scientific purposes; radioactive elements for scientific purposes
42 Research and development for the pharmaceutical industry; provision of research and development services in the field of radionuclides, chemicals and chemical agents; consultancy relating to pharmaceutical research and development; scientific consultancy services in the field of radionuclides, chemicals, and chemical agents
The mark consists of the stylized wording "CERNT" with the "CE" and "T" in grey and the "RN" in blue with a design of a grey plain line square dissected into four equal quadrants with a blue circle in each quadrant. There are four smaller grey plain line squares, one at each corner of the center square with the center square slightly overlapping the squares at the corners. Each of the smaller squares is dissected by a grey diagonal band emanating from the corner of the larger square and each of the parts of the smaller squares is and contains a small blue circle that is connected by a blue line to a larger blue circle in the center square. The color white represents background and transparent areas and is not a feature of the mark.
CENTER FOR ENHANCED RADIONUKLIDE THERANOSTICS
The color(s) blue and grey is/are claimed as a feature of the mark.
Nov 3, 2022
Sn Assigned For Sect 66a Appl From Ib
Nov 4, 2022
New Application Office Supplied Data Entered
Nov 8, 2022
Application Filing Receipt Mailed
Jun 30, 2023
Assigned To Examiner
Jul 5, 2023
Non-Final Action Written
Jul 6, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Aug 9, 2023
Refusal Processed By Mpu
Aug 9, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Aug 28, 2023
Refusal Processed By Ib
Feb 1, 2024
Teas Response To Office Action Received
Feb 1, 2024
Correspondence Received In Law Office
Feb 1, 2024
Teas/Email Correspondence Entered
Feb 4, 2024
Approved For Pub - Principal Register
Feb 21, 2024
Notification Of Possible Opposition Sent To Ib
Feb 21, 2024
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 21, 2024
Notification Of Notice Of Publication E-Mailed
Mar 11, 2024
Notification Processed By Ib
Mar 12, 2024
Published For Opposition
Feb 21, 2024
Official Gazette Publication Confirmation E-Mailed
Apr 3, 2024
Notification Of Possible Opposition Sent To Ib
Apr 3, 2024
Notification Of Possible Opposition Created, To Be Sent To Ib
Apr 22, 2024
Notification Of Possible Opposition - Processed By Ib
Mar 12, 2024
Official Gazette Publication Confirmation E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
